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Background: Asthma has been linked to obesity and the presence of the metabolic syndrome.
Objective: To explore which components of the metabolic syndrome that were associated
with wheezing, a main symptom of asthma. Further, to explore whether these associations
were different in individuals with and without rhinitis symptoms.
Methods: We used data from the Ibermutuamur Cardiovascular Risk Assessment Plan (ICARIA)
including 85,555 Spanish workers (median ageZ 34, rangeZ 16e75 years) with assessments of
self reported wheezing and rhinitis symptoms. Fasting blood samples were analysed for serum
triglyceride (s-TG), HDL (s-HDL) and glucose; blood pressure, waist circumference (WC) and
body mass index (BMI) were measured.
Results: In mutually adjusted analyses including all components of the metabolic syndrome
and possible confounders, elevated WC (or BMI), elevated s-TG and low s-HDL were signifi-
cantly associated with wheezing. Odds ratio (OR) with confidence interval (CI) were: elevated
WC Z 1.54 (1.46e1.62), elevated s-TG Z 1.24 (1.18e1.30), low s-HDL Z 1.17 (1.12e1.22).
These associations were stronger in individuals without than in those with rhinitis symptoms,
OR’s (CI’s) were WC Z without rhinitis 1.70 (1.57e1.85) vs. with rhinitis 1.47 (1.37e1.58).
Elevated s-TG Z without rhinitis 1.36 (1.26e1.46) vs. with rhinitis 1.21 (1.13e1.29). Low s-
HDL Z without rhinitis 1.24 (1.15e1.34) vs. with rhinitis 1.11 (1.04e1.18).ce; s-TG, serum triglyceride; s-HDL, serum HDL cholesterol.
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Serum lipids and wheezing 817Conclusions: High s-TG and low s-HDL were associated with wheezing after adjustment for
adiposity. This may substantiate elevated s-TG and lowered s-HDL as markers or inducers of
inflammation associated disease. The study supports the notion that these biochemical
markers have differential effects on different types of wheezing.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
Epidemiological studies1 and studies of the effects ofweight-
loss2 have clearly shown a link between obesity and asthma,
as a well as an association between the metabolic syndrome
itself and asthma.3 However, the type of asthma associated
with obesity differs from other types of asthma.4,5 Cluster
analyses indicate that the obesity-associated asthma is
characterised by late-onset, is driven by other than eosino-
philic cells, and is mainly found among non-atopics.6
Accordingly, this obesity-associated non-atopic asthma is
less responsive to corticosteroid treatment.7,8
The mechanisms underlying the link between obesity
and asthma are not fully understood. Obesity can lead to
adipose tissue dysfunction and a chronic state of low-grade
inflammation.9,10 Dysfunctional adipose tissue is charac-
terised by endoplasmatic reticulum stress9 and reduced
uptake of dietary fatty acids in the adipocytes, leading to
dyslipidemia, which may be manifested by hyper-
triglyceridemia and reduced HDL cholesterol levels.11 Fac-
tor analyses have shown hypertriglyceridemia and serum
HDL (s-HDL) to be independent predictors of lung function
impairment.12 Thus, we reasoned that dyslipidemia might
also confer a risk of asthma, independently of the level of
adiposity. This would lend support to that obesity-
associated asthma in non-atopics could be part of the
cluster of diseases, such as cardiovascular diseases13e15 and
non-alcoholic fatty liver disease,16 as suggested earlier.10 In
these diseases, hypertriglyceridemia seems to be an inde-
pendent risk factor and not simply a marker of the level of
obesity or of other serum lipid levels.17,18 Thus, among the
factors of the metabolic syndrome, hypertriglyceridemia
and reduced s-HDL could also be involved in asthma path-
ogenesis independently of the level of adiposity.
The present study tested the hypothesis that factors
associated with adipose tissue dysfunction, namely
elevated serum triglyceride (s-TG) and lowered s-HDL, are
predictive of wheezing, a symptom of asthma, indepen-
dently of obesity. We also investigated whether associa-
tions of these biomarkers with wheezing would differ in
persons with and without rhinitis symptoms since rhinitis is
associated with atopy.Methods
Study design
We analysed data from the Ibermutuamur Cardiovascular
Risk Assessment Plan (ICARIA) study, which is an on-going
study of workers covered by Ibermutuamur, a nationwide
Social Security mutual insurance company for accidents atwork and occupational diseases that covers a population of
approximately one million workers corresponding to 8% of
the Spanish working population. Ibermutuamur has a
department for prevention and health of workers, who are
given routine annual medical check-ups, and the ICARIA
study, described elsewhere,19 examines data taken at
the time of the annual check-up, based on the physical
examination, laboratory determinations, and a physician-
administered structured questionnaire. Local Ethics Com-
mittees have reviewed and approved the ICARIA study, and
all subjects provided written, informed consent to partic-
ipate in the study.
The current study is cross-sectional and based on an extra
self-administered, structured questionnaire of health-
related items including questions of bronchial and nasal
symptoms, that was completed (March 2005 to March 2007)
by a random sample of 102,961 workers, who were stratified
by region of origin in order to ensure nationwide represen-
tation.20 From among all workers who answered the extra
questionnaire, we selected those with we selected those
with complete data on age, gender, and wheezing,
nZ 85,555. There was no difference in any of the covariates
used for the analyses between those with complete data on
age, gender, and wheezing and those without complete data
on one, two, or all three of these variables. We analysed
data from medical records and questionnaire responses.
Bronchial and nasal symptoms
The presence of (a) bronchial and (b) nasal symptoms was
explored by means of questions on the self-administered
questionnaire that were adopted from previously validated
questionnaires,21 as follows:
a) Have you ever had wheezing or whistling in the chest at
any time in the last 12 months?
b) Have you ever had a problem with sneezing, or a runny,
or a blocked nose when you did not have a cold or the
flu in the last 12 months?
Adiposity measures
Anthropometric measurements were made with the sub-
jects wearing light clothing and without shoes. Height was
measured to the nearest cm, and weight to the nearest
0.1 kg. Waist circumferencewasmeasured to the nearest cm
using a tape measure with no pressure on the body surface.
Metabolic abnormalities
Biochemical determinations were performed using
serum samples obtained under fasting conditions. The
Table 1 Wheezing according to characteristics of the
study population.
Prevalence,
wheezing
Risk of
wheezing
% (n/all) aOR (CI)
Age
<45 years 17.8 (12021/67390) Reference
45 years 18.8 (3408/18165) 1.04
(1.00e1.08)
Gender
Females 15.2 (3686/24315) Reference
Males 19.2 (11743/61240) 1.32
(1.27e1.38)
Rhinitis symptoms
Absent 9.3 (4561/48791) Reference
Present 29.9 (10243/34295) 4.20
(4.04e4.36)
BMI
<18.5 kg/m2 18.1 (257/1421) 1.20
(1.04e1.37)
18.5e25 kg/m2 16.0 (6239/38918) Reference
25e30 kg/m2 18.1 (5816/32120) 1.11
(1.06e1.16)
30 kg/m2 24.1 (2999/12463) 1.59
(1.51e1.68)
WC
Normalb 17.0 (11074/65329) Reference
Highb 24.5 (2701/11025) 1.58
(1.51e1.66)
S-Triglycerides
<150 mg/dl 16.7 (11448/68472) Reference
150e400 mg/dl 23.9 (3200/13416) 1.50
(1.44e1.57)
400 mg/dl 28.6 (269/942) 1.90
(1.64e2.19)
S-HDL
Normalb 17.2 (11308/65728) Reference
Lowb 22.2 (3361/15167) 1.38
(1.32e1.44)
S-LDL
Normalb 18.0 (13600/75564) Reference
Highb 18.3 (1829/9991) 0.98
(0.93e1.03)
S-glucose
Normalb 17.8 (13456/75510) Reference
Highb 19.6 (1973/10045) 1.07
(1.01e1.13)
Blood pressure
Normalb 17.5 (9098/52097) Reference
Highb 18.9 (6331/33458) 1.05
(1.01e1.09)
Metabolic syndrome
Absentb 17.2 (10892/63149) Reference
Presentb 25.4 (2113/8334) 1.58
(1.49e1.67)
Occupation
High level
(non-manual)c
20.0 (10104/50414) Reference
Low level
(manual)c
15.2 (5325/35141) 1.33
(1.28e1.38)
Table 1 (continued )
Prevalence,
wheezing
Risk of
wheezing
% (n/all) aOR (CI)
Alcohol consumption
0e<70 g/week 16.8 (11367/67475) Reference
70e<280 g/week 21.8 (3609/16519) 1.31
(1.25e1.37)
>280 g/week 29.0 (453/1561) 1.91
(1.71e2.14)
Tobacco use
Never smoker 9.2 (3055/33215) Reference
Former smoker 12.1 (1843/15241) 1.29
(1.22/1.38)
Current smoker 28.4 (10495/36914) 3.90
(3.73/4.07)
Physical activity at work
Sedentary 15.7 (5279/33627) Reference
Standing 17.3 (3090/17883) 1.09
(1.04e1.15)
Walking 19.6 (3686/18786) 1.26
(1.20e1.32)
Physically
demanding
24.5 (2084/8517) 1.64
(1.55e1.75)
%, percentage of individuals with wheezing in the specific
group; (n/all), number of individuals with wheezing/number of
all individuals in the specific group.
a Odds ratio (OR) estimates with 95% confidence intervals (CI)
were obtained in logistic regression models adjusted for age and
gender only; BMI, body mass index; WC, waist circumference;
HDL, high density lipoprotein cholesterol; LDL, low density li-
poprotein cholesterol.
b Defined according to ATP III criteria23: abdominal adiposity
(waist circumference >102 cm in male subjects or >88 cm in
female subjects); high blood pressure (>130/85 mmHg or pre-
vious diagnosis of or therapy for hypertension); hyper-
triglyceridemia (fasting serum triglycerides >150 mg/dl); low
HDL cholesterol (<40 mg/dl in male subjects or <50 mg/dl in
female subjects); and high serum glucose (>110 mg/dl or pre-
vious diagnosis of or therapy for diabetes). Metabolic syndrome
was considered when at least three of these criteria were
present.
c Defined according to the Spanish National Classification of
Occupations.24
818 R.V. Fenger et al.Friedewald equation was used to calculate LDL-choles-
terol.22 All measurements were performed in automatic
analysers at reference laboratories following uniform
standard procedures and quality controls, as detailed
elsewhere.19
Metabolic abnormalities were defined according to the
Adult Treatment Panel III (ATP III) (2001) criteria for meta-
bolic syndrome.23 Metabolic syndrome was considered when
at least three of the following criteria were present: 1)
abdominal adiposity (waist circumference >102 cm in male
subjects or >88 cm in female subjects); 2) high blood pres-
sure (pressure >130/85 mmHg or previous diagnosis of or
therapy for hypertension); 3) hypertriglyceridemia (fasting
serum triglycerides>150 mg/dl); 4) low s-HDL (<40 mg/dl in
male subjects or <50 mg/dl in female subjects); and 5)
Table 2 Association of self reported wheezing with selected risk factors. Analyses with either waist circumference (upper
panel) or with body mass index (lower panel).
Analyses with WC Not mutually
adjusted
Categorical obesity
measures
Continuous obesity
measures
Model 1* Model 2** Model 3**
aOR (CI) aOR (CI) aOR (CI)
Waist circumference categorical
Normalb Reference Reference
Highb 1.63 (1.55e1.72) 1.54 (1.46e1.62)
Waist circumference continuous
One standard deviation 1.28 (1.25e1.31) 1.24 (1.22e1.27)
S-Triglycerides
Normalb Reference Reference Reference
Highb 1.36 (1.30e1.42) 1.24 (1.18e1.30) 1.20 (1.14e1.26)
S-HDL
Normalb Reference Reference Reference
Lowb 1.28 (1.22e1.34) 1.17 (1.12e1.22) 1.14 (1.08e1.19)
Analyses with body mass index Model 1* Model 2** Model 3***
aOR (CI) aOR (CI) aOR (CI)
Body mass index categorical
<18.5 kg/m2 1.10 (0.95e1.27) 1.11 (0.96e1.28)
18.5e<25 kg/m2 Reference Reference
25e<30 kg/m2 1.19 (1.14e1.25) 1.15 (1.11e1.21)
>30 kg/m2 1.73 (1.64e1.82) 1.61 (1.52e1.70)
Body mass index continuous
One standard deviation 1.23 (1.20e1.25) 1.20 (1.17e1.22)
S-Triglycerides
Normalb Reference Reference Reference
Highb 1.36 (1.30e1.42) 1.20 (1.14e1.26) 1.20 (1.14e1.26)
S-HDL
Normalb Reference Reference Reference
Lowb 1.28 (1.22e1.34) 1.16 (1.11e1.21) 1.15 (1.09e1.20)
*Model 1, models in the left column were adjusted for potential confoundersa but there was not a mutual adjustment of obesity
measures and serum lipids.
**Model 2 and Model 3 were adjusted for potential confounders and for one obesity measure (WC upper panel, BMI lower panel), S-TG
and S-HDL. Model 2 included categorical obesity measures, Model 3 included continuous obesity measures. aPotential confounders: age,
sex, education, alcohol, tobacco and physical activity during working hours.
a Odds ratio (OR) estimates with 95% confidence intervals (CI) were obtained in logistic regression models. WC, waist circumference;
HDL, high density lipoprotein; BMI, body mass index.
b Defined according to ATP III criteria23: abdominal adiposity (waist circumference >102 cm in male subjects or >88 cm in female
subjects); hypertriglyceridemia (fasting serum triglycerides >150 mg/dl); low HDL cholesterol (<40 mg/dl in male subjects or <50 mg/dl
in female subjects).
Serum lipids and wheezing 819hyperglycemia (fasting serum glucose >110 mg/dl or previ-
ous diagnosis of or therapy for diabetes).23
Occupational data
Specific occupations were classified into nine major cate-
gories according to the 1994 Spanish National Classification
of Occupations.24 Non-manual (white-collar) workers were
defined as those in the first four categories1: general
managers and government administrators2; scientific pro-
fessionals, technicians and intellectuals3; support techni-
cians and professionals4; clerks and related office
personnel. Manual (blue-collar) workers were defined as
those in the remaining five categories5: catering and hos-
pitality, personal and security service workers, andsalesmen/women and shop assistants6; skilled workers in
agricultural and fishing industries7; craftsmen/women and
skilled workers in manufacturing, construction, and min-
ing8; machine installers, operators, and assemblers; and9
unskilled workers. Physical activity during working hours
was classified as sedentary, standing, walking, or physically
demanding.
Lifestyle factors
Alcohol consumption was evaluated as the number of
standard drinking units (glasses of wine [w10 g], bottles of
beer [w10 g], and spirits [w10 g]) regularly consumed per
week. Individuals were classified as current smokers, ex-
smokers, and never smokers.
Figure 1 Risk of wheezing per standard deviation of s-HDL
and s-TG by level of BMI. Diamonds: s-HDL; squares: s-TG. Odds
ratio estimates with 95% confidence intervals indicated by
error bars were obtained in one single logistic regression model
adjusted for age, sex, adiposity, occupation, alcohol, and
physical activity during working hours. S-TG, serum triglycer-
ide; s-HDL, serum high density lipoprotein.
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Statistics were performed using the R-statistical package,
version 2.13.0 (http://www.r-project.org/). All p-values
were two-tailed and statistical significance was defined as
p < 0.05. P-values of likelihood ratio tests were used to test
for significance of all multivariate analyses. We used lo-
gistic regression to model wheezing and rhinitis symptoms.
We checked for nonlinear associations between all
explanatory variables and logit of the dichotomous out-
comes using P-splines within the generalised additive model
(R “mgcv” package). For variables with non-linear associ-
ations with logit of the dichotomous outcomes, splines were
used in the regression models. We tested possible in-
teractions between adiposity measures (BMI or WC) and
serum lipids (s-TG of s-HDL) in the regression models. We
also tested possible interactions of adiposity measures and
serum lipids with both gender and rhinitis symptoms. All
multivariate analyses were made with the adiposity mea-
sures, the serum lipids, serum glucose and blood pressure
as both categorised according to the definitions of the
metabolic syndrome and as continuous. We standardised
the continuous variables by dividing each variable by its
own standard error to facilitate comparison of theFigure 2 Risk of wheezing per standard deviation of s-HDL and s-
years and 45 years or older. Diamonds: s-HDL; squares: s-TG. Odds r
bars were obtained in logistic regression models adjusted for age, s
working hours. S-TG, serum triglyceride; s-HDL, serum high densitmagnitude of effects between the different variables. All
analyses were checked for the possible influence of out-
liers. The consistency of the results was also checked by
performing all regression analyses both with and without
the highest and lowest percentages of observations of the
explanatory variables. Further, we made several subgroup
analyses: First, we repeated all analyses in the three cat-
egories of smoking, namely in never smokers, former
smokers and current smokers. Second, we repeated all
analyses in individuals younger than 45 years and in in-
dividuals 45 years or more. The age-divided analyses were
made to compensate for the likely inclusion of COPD-
related wheezing in individuals of 45 years or more.Results
The study population consisted of 85,555 individuals (39.7%
female), with a median age of 34 years (range: 16e75
years). The prevalence of wheezing was 18.0% (95% CI
17.8e18.3%). Table 1 presents the initial analyses of the
risk of wheezing adjusted only for sex and age. Wheezing
was positively associated with BMI, waist circumference,
and the presence of high s-TG level, high blood pressure,
and metabolic syndrome. Wheezing was inversely associ-
ated with s-HDL level. In multiple regression analyses
(Table 2), obesity (assessed as either BMI or waist circum-
ference), elevated s-TG level, and low s-HDL level
remained significantly associated with wheezing after
mutual adjustment of serum lipid level and adiposity (both
as categorical and continuous variables). Fig. 1 displays
data for the lipids by six levels of BMI. Results are given per
standard deviation of each variable (standardized effects),
allowing a direct comparison of the strength of the asso-
ciation of s-TG vs. s-HDL with wheezing. The level of s-TG
and s-HDL seemed associated with wheezing with fairly the
same strength and these associations were fairly similar in
normal weight individuals and in overweight/obese in-
dividuals. Further, we found no statistically significant in-
teractions between lipid levels and BMI in relation to risk of
wheezing (for all interactions, p > 0.23).
Smoking status was significantly associated with serum
lipids, adiposity and wheezing. Yet, in subgroups of never,
former, and current smokers, results were essentially
similar to those obtained in the total population. ConsistentTG by level of BMI (six quantiles) in individuals younger than 45
atio estimates with 95% confidence intervals indicated by error
ex, adiposity, occupation, alcohol, and physical activity during
y lipoprotein.
Serum lipids and wheezing 821with this, test for interaction between smoking status in
three categories (never, former, and current smokers) and
the lipids and/or adiposity measures were insignificant, p-
values > 0.30, tobacco*BMI p Z 0.11.
The associations presented above seemed stronger in the
population younger than 45 years than in the population
older than 45 years (Fig. 2), even though there was no sig-
nificant interaction of age or age-splines with serum lipids.
The associations of adiposity, s-TG and s-HDL with
wheezing were stronger in persons without rhinitis symp-
toms than in persons with rhinitis symptoms (Table 3). For
the metabolic syndrome as a whole, the risk estimates of
wheezing were OR (CI) Z 1.37 (1.16e1.62) with rhinitis,
but OR (CI) Z 2.76 (2.21e3.43) without concurrent rhinitis
(p < 0.001).
The other two serum measures we examined (s-LDL and
s-total cholesterol) showed no significant associations with
wheezing in any of the analyses. Alcohol consumption and
lower educational level were positively associated withTable 3 Association of adiposity (body mass index, upper panel,
HDL with self reported wheezing in the rhinitis and non-rhinitis p
Analyses with WC Risk of wheeze
Rhinitis population
ORa (CI)
Waist circumference
Normald Reference
Highd 1.47 (1.37e1.58)
S-Triglycerides
Normald Reference
Highd 1.21 (1.13e1.29)
S-HDL
Normald Reference
Lowd 1.11 (1.04e1.18)
Analyses with body
mass index
Risk of wheeze
Rhinitis population
ORa (CI)
Body mass index
<18.5 kg/m2 1.20 (1.00e1.44)
18.5e<25 kg/m2 Reference
25e<30 kg/m2 1.16 (1.10e1.23)
>30 kg/m2 1.58 (1.47e1.71)
S-Triglycerides
Normald Reference
Highd 1.18 (1.10e1.26)
S-HDL
Normald Reference
Lowd 1.09 (1.03e1.17)
The rhinitis population was defined as those with self-reported rhinit
a Odds ratio (OR) estimates with 95% confidence intervals (CI) we
education, alcohol, tobacco, and physical activity during working h
respectively.
b Interaction p-value, log likelihood test of significance of the inter
body mass index; f, females; m, males.
c Indicate the p-value for the interaction between BMI in four group
d Defined according to ATP III criteria23: abdominal adiposity (wais
subjects); hypertriglyceridemia (fasting serum triglycerides >150 mg/d
in female subjects).wheezing, and physical activity during working hours was
inversely associated with wheezing (unadjusted data shown
in Table 1). However, none of these variables or gender
changed the adiposity-wheezing association or the associ-
ations of s-TG and s-HDL with wheezing (data not shown)
when included in the regression models.
Analysing rhinitis separately, there were no associations
of rhinitis symptoms with s-TG or measures of adiposity
(Table 4, data shown only for BMI), although low s-HDL was
positively associated with rhinitis symptoms.Discussion
We found that high s-TG and low s-HDL, two of the com-
ponents of the metabolic syndrome, were significantly
associated with wheezing, particularly in persons without
rhinitis symptoms. Notably, these associations persisted
after adjustment for adiposity).and waist circumference, lower panel), s-triglycerides and s-
opulation.
Non-rhinitis population Interactionb
ORa (CI) p-value
Reference
1.70 (1.57e1.85) 0.01
Reference
1.36 (1.26e1.46) 0.02
Reference
1.24 (1.15e1.34) 0.02
Non-rhinitis population Interactionb
ORa (CI) p-value
0.89 (0.66e1.18)
Reference
1.22 (1.13e1.31)
1.87 (1.72e2.05) 0.02c
Reference
1.30 (1.20e1.41) 0.03
Reference
1.23 (1.13e1.32) 0.02
is symptoms.
re obtained in logistic regression models adjusted for age, sex,
ours as well as for the variables in the upper or lower panel
action terms (rhinitis*covariate); WC, waist circumference; BMI,
s and rhinitis.
t circumference >102 cm in male subjects or >88 cm in female
l); low HDL cholesterol (<40 mg/dl in male subjects or <50 mg/dl
822 R.V. Fenger et al.The results presented in this paper seemed to be
stronger in individuals younger than 45 years. We speculate
that wheezing in this group is more likely to be a symptom
of asthma than in individuals older than 45 years, and thus
high s-TG and low s-HDL may be associated with asthma.
However, these results come from subgroup analyses and
must be interpreted with caution.
Our results add to earlier findings that insulin resistance
and the metabolic syndrome are associated with asthma-
like symptoms25 and with asthma,3 and corroborate findings
from a study that found that elevated s-TG and lowered s-
HDL were associated with impaired lung function indepen-
dently of waist circumference.12 Our results are also
consistent with the fact that improved lung function and
reduced asthma severity was noted after duodenal bypass
surgery,26 which significantly improves glycemic control27
and results in major reductions of hepatic triglycerideTable 4 Association of self reported rhinitis symptoms
and selected risk factors.
Risk of rhinitis
symptoms
ORa (CI)
Age (years) 0.99 (0.99e0.99)
Gender
Female Reference
Male 0.80 (0.76e0.83)
Body mass index
Continuous, 1SDb 0.94 (0.92e0.97)
S-Triglycerides
Normalc Reference
Highc 0.99 (0.95e1.03)
S-HDL
Normalc Reference
Lowc 1.04 (1.01e1.09)
Blood pressure
Normalc Reference
Highc 0.95 (0.91e0.98)
S-glucose
Normalc Reference
Highc 0.95 (0.91e1.00)
Physical activity
(Four categories) 1.02 (0.99e1.06)
Occupation
High level (non-manual)d Reference
Low level (manual)d 1.00 (0.95e1.05)
Tobacco
Never smokers Reference
Former smokers 1.07 (1.02e1.11)
Current smokers 1.14 (1.10e1.18)
Alcohol (single units) 1.00 (1.00e1.00)
a Odds ratio (OR) estimates with 95% confidence intervals (CI)
were obtained in logistic regression model adjusted for all
variables in the table.
b SD, standard deviation; HDL, high density lipoprotein
cholesterol.
c Defined according to ATP III criteria.23
d Defined according to the Spanish National Classification of
Occupations.24content16). By contrast, a cross sectional study from Korea
with 9942 participants28 found no association of s-TG and s-
HDL with asthma-like symptoms although it is unclear
whether possible confounders such as smoking, age, and
sex were accounted for in this study. In line with this, a
NHANES-study showed that increasing levels of s-TG and
decreasing levels of s-HDL were associated with a lower risk
of asthma in a study with 7005 individuals29; further there
was a positive association between increasing levels of s-
LDL and risk of asthma.
The observed associations between serum lipids and
wheezing (asthma) raise several possibilities. Firstly,
increasing s-TG and decreasing s-HDL levels could simply be
markers of dysfunctional adipose tissue. This implies that
dysfunctional adipose tissue is different from the total
amount of adipose tissue in the body, as Franssen and
colleagues30 speculated earlier. This notion is supported by
a recent study of hypertriglyceridemia in mice that sug-
gested that elevated s-TG indicates the presence of
metabolically-induced inflammation.31 Another possibility
is that increasing s-TG and decreasing s-HDL could either
initiate or accelerate ongoing systemic inflammation that
would later lead to airway disease, via mechanisms that are
not yet understood. However, both the results of our cross-
sectional study and the subsequent speculations about the
perspectives of the study need to be investigated further in
studies designed for this purpose.
Asthma likely consists of different entities, with early
onset and predominantly atopic asthma contrasting with
late onset and predominantly non-atopic asthma.5 Earlier
studies have found an increased risk of obesity-related
asthma among non-atopics.32,33 We found that adiposity, s-
TG and s-HDL were all more strongly associated with
wheezing in individuals without rhinitis symptoms than in
individuals with symptoms. These associations suggest the
presence of a type of asthma that is associated with low
grade inflammation/metabolic dysfunction. This notion is
supported by another study showing that s-TG was not
associated with atopic sensitization per se34 as well as by our
finding that s-TG was not associated with rhinitis symptoms.
One of the strengths of our study was the high number of
individuals (nZ 85,555) collected from the ICARIA study of
workers from all regions of Spain. Although the young age of
the study population meant that the exposure measures of
interest, the serum lipids, in general were not markedly
elevated/lowered, we nevertheless found consistent asso-
ciations of s-TGs and s-HDL with wheezing.
Limitations of the study include a cross-sectional design
that leaves the direction of the association between serum
lipids and wheezing unknown. A better definition of asthma
would have been preferable as there certainly is a difference
between “wheeze” and “asthma”. Unfortunately the study
was not originally designed for studying asthma. In this case,
several known risk factors for asthma could have been
included, e.g. a better definition of atopy, such as one based
on skin prick test reactivity or elevated IgE-levels to specific
common allergens. Further, we could have differentiated
between individuals with early or late onset wheezing, this
could have strengthened the associations between serum
lipids and late-onset wheezing. We used a rather crude
measure of tobacco exposure categorizing participants in
‘never’, ‘former’, and ‘current’ smokers thatmayhave led to
Serum lipids and wheezing 823residual confounding. However, we found associations of
serum lipids with wheezing in all three categories of tobacco
use. We did not examine the effect of diet, although diet
could influence the level of serum lipids, e.g. through the
amount of fructose, and affect airway inflammation, e.g.
through antioxidants.35,36 Also, genetic pleiotropy could be
another possible confounder of our results as some studies
have indicated a common background for asthma and endo-
crine disorders such as diabetes, and for asthma and meta-
bolic syndrome.37,38 Despite the limitations, most of which
would lead theestimates of theanalyses closer to null,wedid
observe consistent associations of serum lipids with
wheezing.
In conclusion, we found that high s-TG and low s-HDL
were significantly associated with the risk of wheezing in
85,555 Spanish workers and these associations persisted
after adjusting in several ways for adiposity. The finding
that these associations were mainly seen in individuals
without rhinitis symptoms may support the notion that only
specific types of asthma are associated with low-grade
systemic inflammation.
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